OncoTrace\u2122 PAX8 (Clone QR016)<\/strong> is a recombinant rabbit monoclonal antibody (IgG)<\/strong>, developed for the nuclear detection of the PAX8 protein<\/strong> in FFPE<\/strong> tissues. PAX8 belongs to the Paired Box family of transcription factors and is essential in the embryonic development of kidneys, M\u00fcllerian organs and the thyroid<\/strong>. Its restricted expression makes it a highly sensitive and specific marker for tumors originating in these tissues. <\/p>\n OncoTrace\u2122 PAX8<\/strong> is indicated for the evaluation of tumors of M\u00fcllerian, renal and thyroid<\/strong> origin, helping to differentiate primary carcinomas of these organs from metastases. It is an essential marker in diagnostic panels for ovarian, endometrial and renal tumors<\/strong>. <\/p>\n It is used to identify tumors of M\u00fcllerian, renal and thyroid<\/strong> origin, differentiating them from metastases from other sites.<\/p>\n The recombinant format guarantees standardization, high reproducibility and elimination of the variations typical of hybridomas<\/strong>.<\/p>\n Yes. OncoTrace\u2122 PAX8 is validated for use on automated IHQ platforms<\/strong> and in manual protocols. <\/p>\n Keep between 2\u00b0C and 8\u00b0C. Product stable until expiry date even after opening. <\/p>\n Ensure precision and reliability in cancer diagnostics with recombinant technology.<\/strong> Request your quote or sample of OncoTrace\u2122 PAX8 (QR016)<\/strong> now.<\/p>\n","protected":false},"excerpt":{"rendered":" OncoTrace\u2122 PAX8 (QR016) \u2013 Recombinant Antibody for the Diagnosis of Renal, Ovarian, Endometrial and Thyroid Tumors High Specificity in Tumors of M\u00fcllerian, Renal and Thyroid Origin OncoTrace\u2122 PAX8 (Clone QR016) is a recombinant rabbit monoclonal antibody (IgG), developed for the nuclear detection of the PAX8 protein in FFPE tissues. PAX8 belongs to the Paired Box…<\/p>\n","protected":false},"featured_media":16531,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[771],"product_tag":[751,774,458,460,459,775,773,772],"class_list":{"0":"post-17360","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-oncotrace-recombinant-antibodies","7":"product_tag-antibody","8":"product_tag-clone-en","9":"product_tag-easypath-en","10":"product_tag-ihc","11":"product_tag-immunohistochemistry","12":"product_tag-oncology","13":"product_tag-oncotrace-en","14":"product_tag-recombinant","16":"first","17":"instock","18":"shipping-taxable","19":"purchasable","20":"product-type-variable","21":"col-xs-6 col-sm-4","22":"col-md-3 col-lg-2","23":"un-6-cols"},"_links":{"self":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product\/17360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/comments?post=17360"}],"version-history":[{"count":0,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product\/17360\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/media\/16531"}],"wp:attachment":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/media?parent=17360"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_brand?post=17360"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_cat?post=17360"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_tag?post=17360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Why choose the OncoTrace\u2122 PAX8?<\/h2>\n
\n
Diagnostic Applications<\/h2>\n
Comparison: Recombinant vs. hybridoma<\/h2>\n
\n\n
\n \nFeatures<\/th>\n OncoTrace\u2122 Recombinant<\/th>\n Traditional hybridoma<\/th>\n<\/tr>\n<\/thead>\n \n \n Origin<\/strong>\n<\/td>\n Produced in vitro (without animals)<\/td>\n Produced in mice<\/td>\n<\/tr>\n \n \n Reliability<\/strong>\n<\/td>\n Identical performance between batches<\/td>\n Frequent variation<\/td>\n<\/tr>\n \n \n Specificity<\/strong>\n<\/td>\n High affinity, minimal background<\/td>\n Higher risk of cross-reactivity<\/td>\n<\/tr>\n \n \n Standardization<\/strong>\n<\/td>\n Fully controlled<\/td>\n Subject to genetic drift<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Technical Specifications<\/h2>\n
\n
\n
Frequently Asked Questions (FAQ)<\/h2>\n
What is the OncoTrace\u2122 PAX8 antibody used for?<\/h3>\n
What are the advantages of the recombinant format?<\/h3>\n
Is the product compatible with automation?<\/h3>\n
How to store it?<\/h3>\n
Confidence in High Complexity Diagnostics<\/h2>\n